On January 3, 2023, Shanghai Biotree BIOTECH Co., Ltd., a leading Chinese metabolomics research company, announced the completion of a strategic financing round of CNY 10 Million A+.

Cancer detection startup Naveris said Monday it has secured a $33.4 million expansion of its Series A financing round to reach a total investment in the firm of $51 million that will be used to commercialize and advance its early, viral-driven cancer detection tests.

Moderna and Thermo Fisher Scientific Inc.announced a 15-year strategic collaboration agreement to enable dedicated large-scale manufacturing in the U.S. of Spikevax®, Moderna’s COVID-19 vaccine, and other investigational mRNA medicines in its pipeline.

The European Commission has opened an investigation assess whether Illumina's decision to complete its acquisition of Grail is a breach of the “standstill obligation”

Recently, the centers for disease control and prevention in Africa and the African union commission jointly launched a Pathogen genome project (Pathogen Genomics Initiative, PGI).

Arch Venture Partners, an investment company headquartered in Chicago, IL, announced on April 2, 2020 that it closed two new funds, ARCH Venture Fund X and ARCH Venture Fund X Overage, for a total of $1.46 billion combined to invest in earl

BATM Advanced Communications, an Israeli firm focused on real-time technologies for networking and medical laboratories, has agreed to invest up to $30 million in Ador Diagnostics, BATMs joint venture with Gamida for Life. The funds will go